When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 23 Sep 2025
Last updated: 27 Aug 2025

Summary

Definição

História e exame físico

Principais fatores diagnósticos

  • dyspnea
  • cough
  • wheeze
  • changes in sputum volume/color/thickness
  • tachypnea
  • cyanosis

Outros fatores diagnósticos

  • past medical history of COPD
  • tobacco dependence
  • past medical history of gastroesophageal reflux/swallowing dysfunction
  • malaise and fatigue
  • chest tightness
  • features of cor pulmonale
  • environmental/occupational exposure to pollutants or dust
  • change in mental status
  • fever
  • accessory muscle use
  • paradoxical movements of abdomen

Fatores de risco

  • viral infection
  • bacterial infection
  • gastroesophageal reflux/swallowing dysfunction
  • smoking
  • atypical bacterial infection
  • air pollutants
  • change in weather

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • oxygen saturation on pulse oximetry
  • chest x-ray
  • ECG
  • ABG
  • CBC with differential
  • eosinophil count
  • CRP
  • basic metabolic panel for electrolytes, BUN, + creatinine

Investigações a serem consideradas

  • sputum culture + Gram stain
  • respiratory virus diagnostics
  • cardiac troponin
  • B-type natriuretic peptide (BNP)
  • CT scan of chest

Novos exames

  • procalcitonin
  • vitamin D
  • immunoglobulins

Algoritmo de tratamento

Colaboradores

Consultores especialistas

Carolyn L. Rochester, MD

Professor of Medicine

Yale School of Medicine

New Haven

VA Connecticut Healthcare System

West Haven

CT

Declarações

CLR serves on the COPD scientific advisory board for GlaxoSmithKline Pharmaceuticals but has no competing interests pertaining to this publication.

Richard A. Martinello, MD

Associate Professor

Yale School of Medicine

New Haven

CT

Declarações

RAM declares that he has no competing interests.

Revisores

Antonio Anzueto, MD

Professor of Medicine

University of Texas Health

Section Chief

South Texas Veterans Health Care System

San Antonio

TX

Declarações

AA has been a consultant for GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim, Theravance and Grifols. AA has been reimbursed for his services by these companies. AA is a member of the GOLD scientific committee.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2025 report. 2025 [internet publication].Texto completo

Stevermer JJ, Fisher L, Lin KW, et al. Pharmacologic management of COPD exacerbations: a clinical practice guideline from the AAFP. Am Fam Physician. 2021 Jul 1;104(1):Online.Texto completo  Resumo

Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível aqui.

O uso deste conteúdo está sujeito ao nosso aviso legal